Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy
Summary
Pratteln, Switzerland, April 28, 2026 - Santhera Pharmaceuticals (SIX: SANN) announces that the Board of Directors of the Italian Medicines Agency, AIFA, has a...
Description
Pratteln, Switzerland, April 28, 2026 - Santhera Pharmaceuticals (SIX: SANN) announces that the Board of Directors of the Italian Medicines Agency, AIFA, has a...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source